About Cenote Pharma
Cenote Pharma is a Healthcare company based in Newbury (United Kingdom) founded in 2015, and was acquired by Aspire Pharma in March 2024. Medicines for rare metabolic disorders are developed by Cenote Pharma. Its focus areas include Life Sciences, Rare Diseases, Drugs and Metabolic Disorders.
Company details
Cenote Pharma was founded in 2015 and is based in Newbury, United Kingdom. Medicines for the treatment of rare metabolic disorders are developed and manufactured by the company. Focus is placed on carnitine deficiencies, which can affect the metabolism of vital tissues including those in the heart and muscles. Operations center on pharmaceutical development within the biotech sector.
- Headquarters Newbury, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cenotepharma.co.uk
- Acquired by Aspire Pharma (Mar 2024)
- Investors
- Acquired byAspire Pharma
(Mar 2024)
Investors in Cenote Pharma
Cenote Pharma has secured backing from 1 investor. Prominent investors backing the company include Aspire Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutic drugs and medical devices are in-licensed and commercialized. | 2009 | aspirepharma.co.uk | Petersfield, United Kingdom |
Investor details for Cenote Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cenote Pharma
2 dated milestones of Cenote Pharma across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Cenote Pharma is founded.
- Exit Acquired by Aspire Pharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cenote Pharma
Complete news archive for Cenote Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cenote Pharma
Cenote Pharma was founded in 2015.
Cenote Pharma is headquartered in Newbury, United Kingdom. It is registered at Newbury, England, United Kingdom.
Cenote Pharma was founded in 2015 and is based in Newbury, United Kingdom. Medicines for the treatment of rare metabolic disorders are developed and manufactured by the company. Focus is placed on carnitine deficiencies, which can affect the metabolism of vital tissues including those in the heart and muscles. Operations center on pharmaceutical development within the biotech sector.
Cenote Pharma has 1 investor. Key investors include Aspire Pharma.
Yes. Cenote Pharma was acquired by Aspire Pharma in March 2024.